[go: up one dir, main page]

FR2936527B1 - NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES - Google Patents

NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES Download PDF

Info

Publication number
FR2936527B1
FR2936527B1 FR0805340A FR0805340A FR2936527B1 FR 2936527 B1 FR2936527 B1 FR 2936527B1 FR 0805340 A FR0805340 A FR 0805340A FR 0805340 A FR0805340 A FR 0805340A FR 2936527 B1 FR2936527 B1 FR 2936527B1
Authority
FR
France
Prior art keywords
psychiatric disorders
human animals
obtainment
animals presenting
screening medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0805340A
Other languages
French (fr)
Other versions
FR2936527A1 (en
Inventor
Marc Merten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Et Universitaire Fr
Institut National Polytechnique de Lorraine
Original Assignee
Centre Hospitalier Et Univ
Institut National Polytechnique de Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Et Univ, Institut National Polytechnique de Lorraine filed Critical Centre Hospitalier Et Univ
Priority to FR0805340A priority Critical patent/FR2936527B1/en
Priority to PCT/FR2009/051853 priority patent/WO2010034960A1/en
Priority to EP09753158A priority patent/EP2353016A1/en
Publication of FR2936527A1 publication Critical patent/FR2936527A1/en
Application granted granted Critical
Publication of FR2936527B1 publication Critical patent/FR2936527B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des animaux non-humains présentant des troubles envahissants du développement et/ou des désordres psychiatriques, leur procédé d'obtention et leur utilisation pour le criblage de médicaments susceptibles de prévenir, de réduire ou d'annuler substantiellement les troubles envahissants du développement et/ou des désordres psychiatriques.The invention relates to non-human animals having pervasive developmental disorders and/or psychiatric disorders, their method of obtaining and their use for screening drugs capable of preventing, reducing or substantially reversing pervasive developmental disorders and/or psychiatric disorders.

FR0805340A 2008-09-29 2008-09-29 NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES Active FR2936527B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0805340A FR2936527B1 (en) 2008-09-29 2008-09-29 NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES
PCT/FR2009/051853 WO2010034960A1 (en) 2008-09-29 2009-09-29 Non-human animals having psychiatric disorders, method for obtaining same, and use thereof for drug screening
EP09753158A EP2353016A1 (en) 2008-09-29 2009-09-29 Non-human animals having psychiatric disorders, method for obtaining same, and use thereof for drug screening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0805340A FR2936527B1 (en) 2008-09-29 2008-09-29 NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES

Publications (2)

Publication Number Publication Date
FR2936527A1 FR2936527A1 (en) 2010-04-02
FR2936527B1 true FR2936527B1 (en) 2025-03-28

Family

ID=40947575

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0805340A Active FR2936527B1 (en) 2008-09-29 2008-09-29 NON-HUMAN ANIMALS PRESENTING PSYCHIATRIC DISORDERS, METHOD FOR THEIR OBTAINMENT AND THEIR USE FOR SCREENING MEDICINES

Country Status (3)

Country Link
EP (1) EP2353016A1 (en)
FR (1) FR2936527B1 (en)
WO (1) WO2010034960A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021467A1 (en) * 1998-08-27 2002-07-24 Duphar Int Res A NON-HUMAN MAMMER WITH THE ARTIFICIALLY DONATED BRAIN, METHOD FOR TESTING COMPOUNDS OR PHARMACEUTICAL COMPOSITIONS IN THE MAMMER AND USE OF COMPOSITIONS OR COMPOSITIONS.
FR2899973A1 (en) * 2006-04-14 2007-10-19 Univ Henri Poincare Nancy I Et METHOD FOR IN VITRO OR EX VIVO DIAGNOSIS OF PSYCHIATRIC DISORDERS AND / OR INTESTINAL DYSBIOSES

Also Published As

Publication number Publication date
WO2010034960A1 (en) 2010-04-01
FR2936527A1 (en) 2010-04-02
EP2353016A1 (en) 2011-08-10

Similar Documents

Publication Publication Date Title
EP1838320A4 (en) ANTAGONISTS OF CXCR4 FOR THE TREATMENT OF MEDICAL DISORDERS
EP2323667A4 (en) MODULATION OF TRANSTHYRETIN EXPRESSION FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
EP2485797A4 (en) DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DISORDERS
EP1848270A4 (en) TRANSMUCENT ADMINISTRATION OF DRUG COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF ANIMAL DISORDERS
MA28555B1 (en) SUBSTITUTED MORPHOLINE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
EA201001329A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
TW200732321A (en) Fast dissociating dopamine 2 receptor antagonists
ATE482209T1 (en) COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
FR2908999B1 (en) NOVEL DRUG FOR THE INHIBITION, PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS.
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
BRPI0513029A (en) method for producing a carbamylated erythropoietin protein, carbamylated erythropoietin protein, compound, pharmaceutical composition, methods of treating a chronic, sub-chronic and acute disease or condition and treating a disease of the central nervous system or peripheral nervous system, and , use of a compound
EA201001332A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
MA28874B1 (en) Cap for drug delivery devices
MA28791B1 (en) PIPERAZINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
TNSN08140A1 (en)
EA201001330A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
CL2007001734A1 (en) Compounds derived from imidazole condensed with nitrogen heterocycles; pharmaceutical composition; and use to treat or prevent Alzheimer's disease, senile dementia and dementia associated with parkinson's disease among others.
EP2490537A4 (en) MGLUR4 ALLOSTERIC POTENTIALIZERS, COMPOSITIONS, AND METHODS FOR TREATING NEUROLOGICAL DYSFUNCTION
FR2906530B1 (en) PROCESS FOR THE SYNTHESIS OF ESTOLID ESTERS
MA33241B1 (en) Compounds for the treatment of metabolic disorders
UA97826C2 (en) Fast dissociating dopamine 2 receptor antagonists
PL2418201T3 (en) Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin) yl]-4-penten-2-amine p-hydroxybenzoate for the treatment of central nervous system disorders
EP2004164A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE DISORDERS OR INFLAMMATORY DISORDERS
JO2642B1 (en) Fast Dissociating Dopamine 2 Receptor Antagonists
WO2007132314A3 (en) Substituted piperidino phenyloxazolidinones

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: UNIVERSITE DE LORRAINE, FR

Effective date: 20130123

Owner name: CENTRE HOSPITALIER ET UNIVERSITAIRE, FR

Effective date: 20130123

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17